GlobeNewswire·Aug 4, 2026, 8:45 AM ET

Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference

BLOZF

Cannabix Technologies Inc. announced its Marijuana Breath Test (MBT) technology has been invited to present at the Association of Boxing Commissions and Combative Sports (ABC) 38th Annual Conference in Orlando, Florida.
The conference will provide direct access to regulators, athletic commissions, & industry stakeholders responsible for athlete safety & cannabis testing policies in boxing, MMA, Muay Thai, & other combative sports.
Cannabix's MBT offers a non-invasive method to detect recent THC use closer to the time of competition or incidents, addressing the need for objective tools in safety-sensitive activities.
The company's strategic laboratory partner, Omega Laboratories, will support the engagement with forensic expertise & confirmatory testing capabilities led by President Jerry Crosby.
Key benefits of the MBT platform include rapid breath collection, a practical pre-event & post-incident screening workflow, & more consistent decision-making for regulators.
Cannabix is advancing a broader 5-panel breath testing platform to expand commercial applicability to multiple drug classes & markets such as workplace safety, law enforcement, & transportation.
CEO Rav Mlait stated the conference engagement supports the company's strategy to move the MBT system from development into targeted market engagement with organizations needing recent-use detection.
Cannabix Technologies Inc. is a developer of breath-based technologies for marijuana & alcohol testing designed to enhance public safety & reduce impairment-related risks.
The release includes standard forward-looking statements regarding commercial rollout, regulatory approvals, & potential partnerships, noting various risks that could affect actual results.